Promoter methylation of RASSF1A and DAPK and mutations of K-ras and p53 in non-small cell lung cancer patients

被引：0
|
作者：
Liu, Yang
Lan, Qing
Gao, Weimin
Siegfried, Jill
Luketich, James
Keohavong, Phouthone
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] NCI, NIH, DHHS, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
51
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic significance of BRCA1 and RASSF1A promoter hypermethylation in non-small cell lung cancer patients
    Gao, Weiwei
    Zhou, Zheng
    Liu, Ying
    Liu, Daijian
    Feng, Qingqing
    Xu, Yalai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (08): : 8544 - 8549
  • [32] Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins
    Vatan, Ozgur
    Bilaloglu, Rahmi
    Tunca, Berrin
    Cecener, Gulsah
    Gebitekin, Cengiz
    Egeli, Unal
    Yakut, Tahsin
    Urers, Nur
    TUMORI JOURNAL, 2007, 93 (05): : 473 - 477
  • [33] Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer
    Chen, H
    Suzuki, M
    Nakamura, Y
    Ohira, M
    Ando, S
    Iida, T
    Nakajima, T
    Nakagawara, A
    Kimura, H
    ONCOLOGY REPORTS, 2006, 15 (05) : 1281 - 1285
  • [34] Methylation of RASSF1A and CDH13 Genes in Individualized Chemotherapy for Patients with Non-small Cell Lung Cancer
    Zhai, Xu
    Li, Shi-Jun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (12) : 4925 - 4928
  • [35] Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer
    Kim, DH
    Kim, JS
    Park, JH
    Lee, SK
    Ji, YI
    Kwon, YM
    Shim, YM
    Han, J
    Park, J
    CANCER RESEARCH, 2003, 63 (19) : 6206 - 6211
  • [36] Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
    Camps, C
    Sirera, R
    Bremnes, R
    Blasco, A
    Sancho, E
    Bayo, P
    Safont, MJ
    Sánchez, JJ
    Tarón, M
    Rosell, R
    LUNG CANCER, 2005, 50 (03) : 339 - 346
  • [37] Sorafenib in Patients with Advanced Non-small Cell Lung Cancer that Harbor K-Ras Mutations A Brief Report
    Smit, Egbert F.
    Dingemans, Anne-Marie C.
    Thunnissen, Frederik B.
    Hochstenbach, Monique M.
    van Suylen, Robert-Jan
    Postmus, Pieter E.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 719 - 720
  • [38] K-Ras Mutation among Colorectal and Non-Small Cell Lung Cancer Patients
    Zhou, Wei
    Brown, Holly
    Tice, Melissa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S162 - S162
  • [39] Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer
    Wang, J
    Lee, JJ
    Wang, L
    Liu, DD
    Lu, C
    Fan, YH
    Hong, WK
    Mao, L
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6119 - 6125
  • [40] Promoter methylation of Wrap53α, an antisense transcript of p53, is associated with the poor prognosis of patients with non-small cell lung cancer
    Kim, Dong Sun
    Lee, Won Kee
    Park, Jae Yong
    ONCOLOGY LETTERS, 2018, 16 (05) : 5823 - 5828
12345